GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...
Yahoo27d
This blood test screens for 50 different types of cancer. Is it worth the $949 price tag?
Grail's Galleri test screens for more than 50 different types of cancer from a single blood draw. (Getty Images) ...
pharmaphorum1d
Blood drawing robot heading for pivotal trials
Vitestro's blood drawing (phlebotomy) robot is designed to offer a solution to what the company says is a growing shortage of healthcare personnel, coupled with rising demand for blood tests with ...